---
layout: post
title: "Certain Dissolving Microneedle Patches for Cosmetic and Pharmaceutical Use; Institution of Investigation"
date: 2026-02-05 19:08:07 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2020-00509
original_published: 2020-01-15 00:00:00 +0000
significance: 8.00
---

# Certain Dissolving Microneedle Patches for Cosmetic and Pharmaceutical Use; Institution of Investigation

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** January 15, 2020 00:00 UTC
**Document Number:** 2020-00509

## Summary

Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on November 21, 2019, under section 337 of the Tariff Act of 1930, as amended, on behalf of TheraJect, Inc. of Fremont, California. Supplements were filed on November 27 and December 2, 2019. A first amended complaint was filed on December 10, 2019, and a second amended complaint was filed on December 19, 2019. The second amended complaint alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain dissolving microneedle patches for cosmetic and pharmaceutical use by reason of infringement of certain claims of U.S. Patent No. 6,945,952 ("the '952 patent"). The second amended complaint further alleges that an industry in the United States is in the process of being established as required by the applicable Federal Statute. The second amended complaint requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and a cease and desist order. Addresses: The second amended complaint, except for any confidential information contained therein, is available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW, Room 112, Washington, DC 20436, telephone (202) 205-2000. Hearing impaired individuals are advised that information on this matter can be obtained by contacting the Commission's TDD terminal on (202) 205-1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at (202) 205- 2000. General information concerning the Commission may also be obtained by accessing its internet server at https://www.usitc.gov. The public record for this investigation may be viewed on the Commission's electronic docket (EDIS) at https://edis.usitc.gov.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2020/01/15/2020-00509/certain-dissolving-microneedle-patches-for-cosmetic-and-pharmaceutical-use-institution-of)
- API: https://www.federalregister.gov/api/v1/documents/2020-00509

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
